中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
23期
48-48,50
,共2页
泮托拉唑%枸橼酸铋钾%胃溃疡%愈合%不良反应
泮託拉唑%枸櫞痠鉍鉀%胃潰瘍%愈閤%不良反應
반탁랍서%구연산필갑%위궤양%유합%불량반응
Pantoprazole%Bismuth potassium citrate%Gastric ulcer%Adverse reaction
目的:探讨泮托拉唑联合枸橼酸铋钾治疗胃溃疡的临床疗效。方法:收治胃溃疡患者80例,随机分为研究组和对照组,两组患者均接受常规治疗,纠正水电解质、酸碱平衡。研究组在常规治疗的基础上采用泮托拉唑和枸橼酸铋钾,对照组在常规治疗的基础上单采用枸橼酸铋钾,疗程4周。结果:研究组的治疗有效率92.50%高于对照组的75.00%,疗效差异有统计学意义(P<0.05)。研究组的临床症状和病灶消失所需时间少于对照组(P<0.05)。结论:泮托拉唑联合枸橼酸铋钾治疗胃溃疡可缩短治疗疗程,促进胃溃疡愈合,不良反应少。
目的:探討泮託拉唑聯閤枸櫞痠鉍鉀治療胃潰瘍的臨床療效。方法:收治胃潰瘍患者80例,隨機分為研究組和對照組,兩組患者均接受常規治療,糾正水電解質、痠堿平衡。研究組在常規治療的基礎上採用泮託拉唑和枸櫞痠鉍鉀,對照組在常規治療的基礎上單採用枸櫞痠鉍鉀,療程4週。結果:研究組的治療有效率92.50%高于對照組的75.00%,療效差異有統計學意義(P<0.05)。研究組的臨床癥狀和病竈消失所需時間少于對照組(P<0.05)。結論:泮託拉唑聯閤枸櫞痠鉍鉀治療胃潰瘍可縮短治療療程,促進胃潰瘍愈閤,不良反應少。
목적:탐토반탁랍서연합구연산필갑치료위궤양적림상료효。방법:수치위궤양환자80례,수궤분위연구조화대조조,량조환자균접수상규치료,규정수전해질、산감평형。연구조재상규치료적기출상채용반탁랍서화구연산필갑,대조조재상규치료적기출상단채용구연산필갑,료정4주。결과:연구조적치료유효솔92.50%고우대조조적75.00%,료효차이유통계학의의(P<0.05)。연구조적림상증상화병조소실소수시간소우대조조(P<0.05)。결론:반탁랍서연합구연산필갑치료위궤양가축단치료료정,촉진위궤양유합,불량반응소。
Objective:To investigate the clinical efficacy of pantoprazole combined with bismuth potassium citrate in the treatment of patients with gastric ulcer.Methods:80 patients with gastric ulcer were selected.They were randomly divided into the study group and the control group.Two groups of patients received conventional treatment,correct water,electrolyte, acid-basebalance.Patients of the study group were treated with pantoprazole combined with bismuth potassium citrate on the basis of routine treatment.Patients in the control group using single bismuth potassium citrate on the basis of routine treatment,the course of 4 weeks.Results:The effective rate of the study group of 92.50% was higher than the control group of 75%,and the difference was significantly different(P<0.05).The clinical symptoms and disappeared time of the lesions of the study group were less than those of the control group(P<0.05).Conclusion:Pantoprazole combined with bismuth potassium citrate in the treatment of patients with gastric ulcer can shorten the course of treatment,promote gastric ulcer healing and with less adverse reaction.